Wowtale reports Adaptyv Bio raised $40 million to automate validation of AI-designed proteins
Wowtale reports that Lausanne-based Adaptyv Bio raised a $40 million Series A to expand automated wet-lab services for testing AI-designed proteins, including DNA synthesis, cell-free expression and binding measurements. The funding, customer figures and performance claims have not been independently confirmed.